Biagi J, MacKenzie R G, Lim M S, Sapp M, Berinstein N
Divisions of Medical Oncology and Hematology, Toronto, Ontario, Canada.
Neuro Oncol. 2000 Oct;2(4):239-43. doi: 10.1093/neuonc/2.4.239.
Primary Hodgkin's disease limited to the CNS is exceedingly rare. Little is known regarding etiologic risk factors, optimal management, and prognosis. A case of Hodgkin's disease confined to the CNS, with cerebrospinal fluid negative for cytology, is described in an immunocompetent patient previously treated for hyperthyroidism with 131I. The patient underwent craniotomy, with resection of two lesions in close proximity within the parenchyma of the temporoparietal lobe. Histopathology revealed classic nodular sclerosing Hodgkin's disease, without evidence of Epstein-Barr viral infection. Treatment included radiation to the whole brain with a boost to the tumor bed. The patient made a full neurologic recovery and remains free of disease recurrence 21 months after treatment. A literature review has identified only 9 additional cases. Seven of 8 evaluable patients remain alive and free of recurrence with a median follow-up of 13 months. The risk factors for this presentation remain undefined. Although follow-up is short, radiotherapy alone appears to provide excellent disease-free survival. Chemotherapy may be reserved for patients with positive cerebrospinal fluid, extracranial disease, or subsequent relapse.
原发性霍奇金淋巴瘤局限于中枢神经系统极为罕见。关于其病因危险因素、最佳治疗方法及预后,人们了解甚少。本文描述了一例免疫功能正常的患者,既往因甲状腺功能亢进接受过¹³¹I治疗,其霍奇金淋巴瘤局限于中枢神经系统,脑脊液细胞学检查呈阴性。该患者接受了开颅手术,切除了颞顶叶实质内紧邻的两个病灶。组织病理学显示为经典的结节硬化型霍奇金淋巴瘤,无爱泼斯坦-巴尔病毒感染证据。治疗包括全脑放疗并对瘤床进行加量照射。患者神经功能完全恢复,治疗后21个月仍无疾病复发。文献综述仅发现另外9例病例。8例可评估患者中有7例存活且无复发,中位随访时间为13个月。这种表现的危险因素仍不明确。尽管随访时间较短,但单纯放疗似乎能提供良好的无病生存期。化疗可用于脑脊液阳性、有颅外疾病或随后复发的患者。